MIST

Milestone Pharmaceuticals Inc.

Price

$0.91

return (12m)

-52.40%

p/e

-1.48

p/bv

6.84

DIVIDEND YIELD

0.00%

MIST price

Milestone Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment MIST

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-12.95%

3 months

-29.69%

1 year

-52.40%

2 years

-41.03%

5 years

-83.62%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals MIST

Valuation

P/E

-1.48

Sector -3.50

Industry -3.50

P/BV

6.84

Sector 2.02

Industry 2.02

P/Revenue (PSR)

53.15

Sector 2.01

Industry 2.01

EV/EBITDA

-0.55

Sector -214.99

Industry -214.99

EV/EBIT

-0.55

Sector -47.59

Industry -47.59

P/EBITDA

-1.71

Sector -21.41

Industry -21.41

P/EBIT

-1.70

Sector -28.65

Industry -28.65

P/Total Assets

0.69

Sector 1.19

Industry 1.19

P/Net Current Assets

7.36

Sector -11.97

Industry -11.97

P/Working Capital

0.79

Sector -167.95

Industry -167.95

EPS

-0.62

Sector -1.81

Industry -1.81

BVPS

0.13

Sector 2.06

Industry 2.06

Efficiency

Gross Margin

98.04%

Sector 41.30%

Industry 41.30%

EBITDA Margin

-4,263.33%

Sector -17,117.21%

Industry -17,117.21%

EBIT Margin

-4,273.52%

Sector -4,185,659.35%

Industry -4,185,659.35%

Operating Margin

-100.00%

Sector -35.21%

Industry -35.21%

Net Profit Margins

-100.00%

Sector -35.91%

Industry -35.91%

Asset Turnover

0.00

Sector 0.02

Industry 0.02

Profitability

ROE

-461.14%

Sector -56.04%

Industry -56.04%

ROA

-46.26%

Sector -60.31%

Industry -60.31%

ROIC

-1,815.96%

Sector -2,335.95%

Industry -2,335.95%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

8.13

Sector 2.89

Industry 2.89

Net Debt / EBITDA

4.67

Sector -14,066,680.10

Industry -14,066,680.10

Net Debt / EBIT

4.66

Sector -8.06

Industry -8.06

Net Debt / Equity

-6.11

Sector -33,024.69

Industry -33,024.69

Gross Debt / Equity

3.25

Sector -0.85

Industry -0.85

Equity/Assets

0.10

Sector 0.46

Industry 0.46

Liabilities/Assets

0.90

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

-31.02%

Sector -

Industry -

5Y Earnings CAGR

14.41%

Sector -

Industry -

Fundamentals MIST

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
MIST Milestone Pharmaceuticals Inc.	$0.91	-52.89%	0.00%	-1.48	6.84	-461.14%	-100.00%
JNJ Johnson & Johnson	$269.33	55.44%	1.96%	30.82	7.63	24.76%	21.48%
PFE Pfizer Inc.	$27.49	22.33%	6.26%	35.85	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$263.93	23.34%	2.59%	73.99	-78.76	-106.44%	9.81%
NVO Novo Nordisk A/S	$43.19	-26.70%	4.29%	10.56	5.61	53.11%	35.32%
MRK Merck & Co. Inc.	$146.11	87.14%	2.31%	113.21	8.55	7.55%	4.76%
AZN AstraZeneca PLC	$166.35	9.78%	1.94%	19.88	5.12	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$62.71	43.77%	4.04%	13.67	5.68	41.55%	18.85%
ZTS Zoetis Inc.	$72.66	-49.60%	2.88%	11.47	9.64	84.02%	27.77%
AMGN Amgen Inc.	$383.04	43.28%	2.60%	23.66	17.70	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$784.44	31.54%	0.47%	18.63	2.54	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$111.35	46.87%	0.00%	31.57	90.97	288.13%	24.86%
MCK McKesson Corporation	$874.67	27.00%	0.38%	19.57	-26.84	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$506.08	30.72%	0.00%	29.15	6.34	21.76%	35.00%
CAH Cardinal Health Inc.	$224.45	52.89%	0.91%	30.53	-19.32	-63.29%	0.68%
ARGX argenx SE	$994.44	35.42%	0.00%	2.24	2.63	117.11%	44.68%
HRMY Harmony Biosciences Holdings Inc.	$42.23	31.71%	0.00%	13.50	2.45	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

MIST Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Milestone Pharmaceuticals

Milestone Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (0 people)

United States

23 years

Founded: 2003

2019

Time since IPO - 7 years

28

Employees

Milestone Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $124.54 million, with shareholders equity totaling $18.22 million.

The company employs approximately 28 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Milestone Pharmaceuticals Inc. reported $2.34 million in revenue, generating net income of $-84.01 million.

Key financial metrics include a P/E ratio of -1.48, a price-to-book (P/B) ratio of 6.84, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker MIST.

Market cap

$124.54 million

Net worth

$18.22 million

$18,218,000.00

Assets

$181.63 million

$181,625,000.00

Total Shares Outstanding

136.26 million

136,257,000

Average Daily Trading Volume

$1.46 million

$1,460,747.80

Sector

Health Care

Industry

Biotechnology

MIST

MIST revenue and profits

Financial Results MIST

DRAG THE FRAME TO SEE MORE DATA

MIST cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$874.67 25,76% (12M)

P/E

19.57

0.38%

ROE

-137.16%

P/BV

-26.84

CAH - Cardinal Health

$224.45 51,61% (12M)

P/E

30.53

0.91%

ROE

-63.29%

P/BV

-19.32

JNJ - Johnson & Johnson

$269.33 56,33% (12M)

P/E

30.82

1.96%

ROE

24.76%

P/BV

7.63

ABBV - AbbVie

$263.93 22,42% (12M)

P/E

73.99

2.59%

ROE

-106.44%

P/BV

-78.76

MRK - Merck & Co.

$146.11 85,19% (12M)

P/E

113.21

2.31%

ROE

7.55%

P/BV

8.55

AZN - AstraZeneca

$166.35 9,17% (12M)

P/E

19.88

1.94%

ROE

25.77%

P/BV

5.12

PFE - Pfizer

$27.49 22,43% (12M)

P/E

35.85

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$874.67 25,76% (12 M)

P/L

19.57

0.38%

ROE

-137.16%

P/VP

-26.84

CAH - Cardinal Health

$224.45 51,61% (12 M)

P/L

30.53

0.91%

ROE

-63.29%

P/VP

-19.32

JNJ - Johnson & Johnson

$269.33 56,33% (12 M)

P/L

30.82

1.96%

ROE

24.76%

P/VP

7.63

ABBV - AbbVie

$263.93 22,42% (12 M)

P/L

73.99

2.59%

ROE

-106.44%

P/VP

-78.76

MRK - Merck & Co.

$146.11 85,19% (12 M)

P/L

113.21

2.31%

ROE

7.55%

P/VP

8.55

AZN - AstraZeneca

$166.35 9,17% (12 M)

P/L

19.88

1.94%

ROE

25.77%

P/VP

5.12

PFE - Pfizer

$27.49 22,43% (12 M)

P/L

35.85

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Milestone Pharmaceuticals (MIST) today?

A cotação de Milestone Pharmaceuticals (MIST) hoje está em US$ 0.91, com uma variação de -52.4% em relação ao último ano. A cotação de Milestone Pharmaceuticals (MIST) iniciou o ano negociando na casa dos US$ 2.02 e hoje está em US$ 0.91. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Milestone Pharmaceuticals (MIST) e dados de ações do Ibovespa e mercados internacionais.

Quando Milestone Pharmaceuticals (MIST) paga dividendos?

Milestone Pharmaceuticals (MIST) não distribuiu dividendos no último ano.

Is Milestone Pharmaceuticals (MIST) a good investment?

Atualmente, Milestone Pharmaceuticals (MIST) está cotada a US$ 0.91, com um P/L de -1.48, representando um desvio de -249% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de -52.4 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de -52.40%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Milestone Pharmaceuticals (MIST) stock?

Investir em ações de Milestone Pharmaceuticals (MIST) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Milestone Pharmaceuticals (MIST) yield today?

A rentabilidade de Milestone Pharmaceuticals (MIST) foi de -12.95% no último mês, -52.40% no último ano e -83.62% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Milestone Pharmaceuticals (MIST) hoje, o investimento total seria de US$ 91.40, com base na cotação atual de US$ 0.91.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 43.51
Em 5 anos: US$ 14.97
Em 10 anos: US$ 91.40

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

MIST

Milestone Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment MIST

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING MIST WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Milestone Pharmaceuticals

Milestone Pharmaceuticals Inc.

United States

23 years

2019

28

PROFIT X PRICE MIST

Financial Results MIST

MIST cash flow

Asset, Revenue and Profit Growth - MIST

MIST balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions